Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

54.83
BATS BZX Real-Time Price
As of 2:13pm ET
 -0.23 / -0.42%
Today’s Change
37.90
Today|||52-Week Range
56.69
+42.75%
Year-to-Date

Today’s Trading

Previous close55.06
Today’s open55.59
Day’s range54.64 - 55.22
Volume191,930
Average volume (3 months)5,528,392
Market cap$97.0B
Data as of 2:13pm ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)-47.25%
Earnings growth (this year)+13.52%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+2.20%
P/E ratio45.7
Price/Sales2.73
Price/Book3.99

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-1.55-1.76%
NVONovo Nordisk-0.42-0.79%
GSKGlaxoSmithKline-0.38-1.07%
BMYBristol-Myers Squibb-1.63-2.57%
Data as of 2:14pm ET, 12/14/2017

Financials

Next reporting dateJanuary 24, 2018
EPS forecast (this quarter)$0.73
Annual revenue (last year)$20.9B
Annual profit (last year)$1.4B
Net profit margin5.06%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Executive VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts